You are here
- Home
- Therapy Areas
- Neuroscience
A Phase I, Single-centre, Double-blind, Randomised, Placebo-controlled, Parallel Group Study to Assess the Pharmacokinetics, Safety and Tolerability of Two Different Extended Release Formulations of Tablets of AZD3241 (300 mg) after Administration of Multiple Doses in Healthy Male and Female Volunteers
- Disease
- pharmacodynamics, pharmacokinetics
- Drug Name
- AZD3241
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- I
- Start Date
- Jan 18, 1971
- Study Name
- D0490C00003
- Study Id
- D0490C00003
- ClinicalTrials.gov ID
- NCT01457807
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
